Cardiovascular Disease Medications are Underured Globally, Study Shows

Cardiovascular Disease Medications are Underured Globally, Study Shows


Credit: Pixabay/CC0 Public Domain

Secondary Prevention Medias for Cardiovascular Diseases (CVD) Are Underured Globally and Additional Strategies to Increase Their Use Are Needed to Improve Cvd Management and Reduce Premature Mortality Rate a study Published in the Journal of the American College of Cardiology,

The study observed participants with CVD from 17 Countries Over 12 years and Found that Medication Use Remains Low With Little Improvement.

Secondary Prevention of CVD Focuses on Preventing Further Health Problems in People Alredy Diagnosed with CVD. This includes managing risk factors through lifestyle changes, medicines and treatments. Without intervention, these patients are at a higher risk of death, future heart attacks, strokes and heart failure.

Leading International Organizations, Such as the World Health Organization (WHO) and the United Nations (Un), Have ISSUED TARGETS Over the Last Decade to Reduce Premature Mortality from And medicines.

“After Examining The Progress of Medication Use For Secondary Cardiovascular (CVD) Prevention, Our Research Indicates that there Continues to be Substantial Undustan IME, and that global targets are unlikely to be reached, “said dr . Philip Joseph, Lead Author of the Study and Scientist at the Population Health Research Institute (Phri) – A Joint Institute of MCMASTER OF MCMASTER University and Hamilton Health Science, Canada.

The Phri Prospective Urban Rural Epidemiology (Pure) Study, A MULTI-NATIONAL, Community-Based, Prospective Cohort Study, Analyzed Over 11,000 Participants Diagnaded with CVD BETWENES Ver 12 years. Participants were from communities in countries at different income levels and was selected based on Criteria representing urban and rural areas.

Participating Countries Include: (Income Level Based on their World Bank Classification at their time of starting the study)

  • High-Income: Canada, Sweden, United Arab Emirates
  • Upper-Middle-Income: Argentina, Brazil, Chile, Malaysia, Poland, South Africa, Türkiye
  • Lower-Middle-Income: China, Colombia, Iran
  • Low-Income: Bangladesh, India, Pakistan, Zimbabwe

Research Results Showed that Medication Use For Secondary CVD Prevention Varied by Country Income Level and was lower at the last study Visit Compared to the first Visit in Every Income Live Excl For. Come Countries.

Overall, the use of at least one medication for secondary prevention started at 41.3% at the baseline study visit, Peaked at 43.1%, and dropped to 31.3% at the last study VISIT. In high-money counties, use declined from 88.8% to 77.3%.

In Upper-Middle-Income Countries, it rose from 55% to 61.1%. In Lower-Middle-Income Countries, It Began at 29.5%, Peaked at 31.7%, and Fell to 13.4%. In low-income countries, it Increased from 20.8%to a peak of 47.3%, then declined to 27.5%. Use of three or more proven medicine classes for secondary prevention was substantically lower in all country income levels.

“Our Findings Sugged that Current Secondary Prevention Strategies Continue to leave The use of secondary cvd prevention medicines in most parts of the world, “Joseph said .

“This Landmark Study Underscores an immense options to improves global cardiovascular health,” Said Harlan M. Kramholz, MD, SM, Harold Hines Jr. Professor at Yale School of Medicine and Editor-in-chiff of Jaccc,

“It is unacceptable that so many individuals world has alredy experienced heart disease are not receiving readily available and intextive tretments that could save lives and preventing E the tools to bridge this gap in care now- We must act urgently. “

Limitations of the Study Include the Analysis of only Sevenne Countries, Although they were from a broad range of geography of geography of geography of geographical areas as well as levels of Economic Development.

The potential for participants to have understoods use may have caused limitation, including the unknown extent to which changes in cohort demogration, cvd duration Se over time. Lastly, The Covid-19 pandemic restricted the ability to conduct research in some counters during part of the last follow-up visit cycle.

More information:
Secondary Prevention Medications in 17 Countries Grouped By Income Level (Pure): A Prospective Cohort Study, Journal of the American College of Cardiology (2025). Doi: 10.1016/j.jacC.2024.10.121

Provided by American College of Cardiology


Citation: Cardiovascular Disease Medications are underured globally, Study Shows (2025, February 3) retrieved 3 February 2025 from

This document is Subject to copyright. Apart from any Fair Dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

(Tagstotranslate) Medicine Research News (T) Medicine Research (T) Health Research News (T) Health Research (T) Health Science (T) Medicine Science

Leave a Comment

Your email address will not be published. Required fields are marked *